Scientific Advisors

Dr. Peter K. Vogt
Professor, Dept. of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA

Dr. Vogt research is on mechanisms of cancer. He served as a scientific advisor to both Microgenics and Calydon. He is a member of the National Academy of Sciences.


Sir John Skehel FRS FMedSci
Secretary, Biological Sciences Division, Royal Society of London

Sir John Skehel FRS FMedSci was Director of the National Institute for Medical Research (UK) from 1987 to 2006, Director of the WHO World Influenza Centre from 1975 to 1993, and currently is Secretary, Biological Sciences Division, Royal Society of London.  His research is on the structure and functions of the influenza virus hemagglutinin (HA) and neuraminidase (NA) membrane glycoproteins. He is a member of the National Academy of Sciences. 


Dr. Peter A. Barry
Director, Center for Comparative Medicine, University of California, Davis

Dr. Barry was Director of the California National Primate Research Center at Davis. His research is on mechanisms of cytomegalovirus (CMV) persistence and pathogenesis, as well as human CMV vaccine strategies as tested in non-human primate models.


Dr. John H. Crowe
Professor of Molecular and Cellular Biology, Emeritus and Director of the Center for Biostabilization Emeritus at UC Davis.

Dr. Crowe is well known for work on stabilization of biomaterials in the frozen and dry states, with many applications in pharmacy and clinical medicine, and he holds, with the University of California, numerous patents in this field.  He is a Fellow of the American Association for the Advancement for Science, Fellow of the Society for Cryobiology, Fulbright Senior Research Scholar, Guggenheim Fellow, and serves on numerous editorial boards for scientific journals. His work was recently featured on NPR’s Science Friday


Vaccine Vision

Verndari was founded with the goal to eliminate needle phobia, and the need for the cold chain, with a cost-effective simple-to-use vaccination that can be mass produced.  Verndari has developed a complete single-dose vaccination kit which includes VaxiPatchTM. VaxiPatch is an “elegantly simple”...

read more
Featured Article
Featured Team Member

Durga Bobba
Member of the Board of Directors

Durga has over 25 years of global commercial biopharma experience. After an initial spell as a sales representative at Parke-Davis, he took on roles of increasing responsibility at major global pharmaceutical companies including Merck, Genentech and Amgen in the areas of Marketing, Product Development, Alliance Management and Business Development.

Durga started his 15-year career at Merck & Co, Inc. in pricing and then held U.S. and global roles that included U.S. brand management, business development and emerging markets.  He ultimately joined the Vaccine Division as Sr. Director of International Commercial Operations and later Executive Director for the Eastern Europe Middle East and Africa region. Durga supported four ex-US launches and helped Merck Vaccines quadruple annual sales to $4 billion to become the world’s number one vaccine company. Durga is currently the Chief Business Officer of SutroVax.  

Durga holds an MBA from Georgetown University where he received the Dean’s Citation for distinguished service and leadership.

read more